🇺🇸 FDA
Patent

US 10836745

Cocrystal, production method thereof, and medicament containing cocrystal

granted A61KA61K31/4725A61P

Quick answer

US patent 10836745 (Cocrystal, production method thereof, and medicament containing cocrystal) held by Takeda Pharmaceutical Company Limited expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4725, A61P, A61P29/00, A61P35/00